Sánchez-Aldehuelo R., Subtil Iñigo J.C., Martínez Moreno B., Gornals J., Guarner-Argente C., Repiso Ortega A., Peralta Herce S., Aparicio J.R., Rodríguez de Santiago E., Bazaga S., Juzgado D., González-Panizo F., Albillos A., Vázquez-Sequeiros E.. EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video). GASTROINTESTINAL ENDOSCOPY. 2022; 96(6)DOI:10.1016/j.gie.2022.07.018. PMID:35870508. IF:7.700(Q1/2D).

Gallego-Durán R., Albillos A., Ampuero J., Arechederra M., Bañares R., Blas-García A., Berná G., Caparrós E., Delgado T.C., Falcón-Pérez J.M., Francés R., Fernández-Barrena M.G., Graupera I., Iruzubieta P., Nevzorova Y.A., Nogueiras R., Macías R.I.R., Martín F., Sabio G., Soriano G., Vaquero J., Cubero F.J., Gracia-Sancho J.. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2022; 45(9)DOI:10.1016/j.gastrohep.2022.02.005. PMID:35248669. IF:1.900(Q4/10D).

Calafat M., Mañosa M., Ricart E., Nos P., Iglesias-Flores E., Vera I., López-Sanromán A., Guardiola J., Taxonera C., Mínguez M., Martín-Arranz M.D., de Castro L., de Francisco R., Rivero M., Garcia-Planella E., Calvet X., García-López S., Márquez L., Gomollón F., Barrio J., Esteve M., Muñoz F., Gisbert J.P., Gutiérrez A., Hinojosa J., Argüelles-Arias F., Busquets D., Bujanda L., Pérez-Calle J.L., Sicilia B., Merino O., Martínez P., Bermejo F., Lorente R., Barreiro-De Acosta M., Rodríguez C., García-Sepulcre M.F., Monfort D., Cañete F., Domènech E.. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. Journal of Crohns & Colitis. 2022; 16(6)DOI:10.1093/ecco-jcc/jjab213. PMID:34864947. IF:8.000(Q1/2D).

de Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., Ripoll C., Abraldes J.G., Albillos A., Baiges A., Bajaj J., Bañares R., Barrufet M., Benajiba L., Berzigotti A., Bureau C., Calvaruso V., Cardenas A., D'Amico G., De Gottardi A., Dell'Era A., Escorsell A., Fallowfield J., Ferral H., Francque S., Gaba R., Garcia-Pagàn J.C., Genescà J., Rodrigues S.G., Gracia-Sancho J., Han G., Hernandez-Gea V., Jia J., Kiladjian J.J., Krag A., Laleman W., La Mura V., Lens S., Luo X., Mandorfer M., Murad S.D., Paradis V., Patch D., Piano S., Pinzani M., Plessier A., Primignani M., Procopet B., Rautou P.E., Rudler M., Sarin S.K., Schepis F., Senzolo M., Shah V., Shukla A., Tandon P., Tellez L., Thabut D., Thiele M., Trebicka J., Tripathi D., Tsochatzis E., Turco L., Turon F., Valla D., Villanueva C., Wanless I., Yoshiji H., Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. JOURNAL OF HEPATOLOGY. 2022; 76(4)DOI:10.1016/j.jhep.2021.12.022. PMID:35120736. IF:25.700(Q1/1D).

Bravo, MS, Berengua, C, Marin, P, Esteban, M, Rodriguez, C, del Cuerpo, M, Miro, E, Cuesta, G, Mosquera, M, Sanchez-Palomino, S, Vila, J, Rabella, N, Marcos, MA. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity. JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1)DOI:10.1128/JCM.01609-21. PMID:34669457. IF:9.400(Q1/2D).

Larrosa M.N., Canut-Blasco A., Benito N., Cantón R., Cercenado E., Docobo-Pérez F., Fernández-Cuenca F., Fernández-Domínguez J., Guinea J., López-Navas A., Moreno M.Á., Morosini M.I., Navarro F., Martínez-Martínez L., Oliver A.. Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; DOI:10.1016/j.eimc.2022.01.004. PMID:36175285. IF:2.500(Q4/8D).

Rivera A., Viñado B., Benito N., Docobo-Pérez F., Fernández-Cuenca F., Fernández-Domínguez J., Guinea J., López-Navas A., Moreno M.Á., Larrosa M.N., Oliver A., Navarro F.. Recomendaciones del Comité Español del Antibiograma (COESANT) para el estudio de sensibilidad in vitro a los antimicrobianos por difusión con discos. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 41(9)DOI:10.1016/j.eimc.2022.04.015. PMID:. IF:(Q/D).

Giannitsioti E., Salles M.J., Mavrogenis A., Rodriguez-Pardo D., Los-Arcos I., Ribera A., Ariza J., Del Toro M.D., Nguyen S., Senneville E., Bonnet E., Chan M., Pasticci M.B., Petersdorf S., Benito N., O'Connell N., Blanco García A., Skaliczki G., Tattevin P., Kocak Tufan Z., Pantazis N., Megaloikonomos P.D., Papagelopoulos P., Soriano A., Papadopoulos A.. Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study. Journal Of Bone And Joint Infection. 2022; 7(6)DOI:10.5194/jbji-7-279-2022. PMID:36644590. IF:(Q/D).

de Mendoza C., Pérez L., Fernández-Ruiz M., Pena M.J., Ramos J.M., Richart A., Piron M., Rando A., Miró E., Reina G., Encinas B., Rojo S., Rodriguez-Iglesias A.M., Benito R., Aguilera A., Treviño A., Corral O., Soriano V.. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2022; 122DOI:10.1016/j.ijid.2022.07.043. PMID:35902023. IF:8.400(Q1/2D).

Mancheño-Losa M., Lora-Tamayo J., Fernández-Sampedro M., Rodríguez-Pardo D., Muñoz-Mahamud E., Soldevila L., Palou M., Barbero J.M., del Toro M.D., Iribarren J.A., Benito N., Sobrino B., Rico-Nieto A., Guío-Carrión L., Gómez L., Escudero-Sánchez R., García-País M.J., Jover-Sáenz A., Praena J., Baraia-Etxaburu J.M., Auñón Á., Múñez-Rubio E., Murillo O.. Corrigendum to “Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort” [Journal of Infection 83 (2021) 542–549] (Journal of Infection (2021) 83(5) (542–549), (S0163445321004527), (10.1016/j.jinf.2021.09.001)). JOURNAL OF INFECTION. 2022; 84(5)DOI:10.1016/j.jinf.2022.01.021. PMID:35105460. IF:(Q/D).

Sojo-Dorado J., López-Hernández I., Rosso-Fernandez C., Morales I.M., Palacios-Baena Z.R., Hernández-Torres A., Merino De Lucas E., Escolà-Vergé L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Giner-Oncina L., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Alvarez R.M., Dueñas C.J., Calvo-Montes J., Silva J.T., Cárdenes M.A., Lecuona M., Pomar V., Valiente De Santis L., Yagüe-Guirao G., Lobo-Acosta M.A., Merino-Bohórquez V., Pascual A., Rodríguez-Baño J.. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA Network Open. 2022; 5(1)DOI:10.1001/jamanetworkopen.2021.37277. PMID:35024838. IF:13.800(Q1/1D).

Tornero-Molina, J, Alperi-Lopez, M, Castellvi, I, de Agustin-de Oro, JJ, Escudero, A, Garcia-Vicuna, R, Gonzalez-Gay, MA, Hidalgo, C, Rubio, E, Sanmarti, R, Casamira, N, Calvo-Alen, J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1)DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. IF:(Q/D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Baute J.J.B., Ibáñez B.J., Toniolo E., Ramírez J., García A.S.. Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 57DOI:10.1016/j.semarthrit.2022.152097. PMID:36113222. IF:5.000(Q2/3D).

Kerick M., Acosta-Herrera M., Simeón-Aznar C.P., Callejas J.L., Assassi S., Carreira P., Castellvi I., Ríos R., Portales R.G., Fernández-Nebro A., García-Hernández F.J., Aguirre M.A., Fernández-Gutiérrez B., Rodríguez-Rodríguez L., de la Peña P.G., Vicente E., Andreu J.L., de Castro M.F., López-Longo F.J., Fonollosa V., Guillén A., Tolosa C., Pros A., Beltrán E., Carballeira M.R., Narváez F.J., Rivas M.R., Ortiz-Santamaría V., Madroñero A.B., González-Gay M.A., Díaz B., Trapiella L., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Díaz F., Roman-Ivorra J.A., Sancho J.J.A., Freire M., Garcia F.J.B., Oreiro N., Kreuter A., Riemekasten G., Airò P., Magro C., Voskuyl A.E., Vonk M.C., Hesselstrand R., Nordin A., Lunardi C., Gabrielli A., Hoffmann-Vold A., Distler J.H.W., Padyukov L., Koeleman B.P.C., Proudman S.M., Nikpour M., Stevens W., Zochling J., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M., Lester S., Vigone B., Pers J.-O., Saraux A., Devauchelle-Pensec V., Cornec D., Jousse-Joulin S., Lauwerys B., Ducreux J., Maudoux A.-L., Vasconcelos C., Tavares A., Neves E., Faria R., Brandão M., Campar A., Marinho A., Farinha F., Almeida I., Mantecón M.A.G.-G., Alonso R.B., Martínez A.C., Cervera R., Rodríguez-Pintó I., Espinosa G., Lories R., De Langhe E., Belz D., Witte T., Baerlecken N., Stummvoll G., Zauner M., Lehner M., Collantes E., Ortega-Castro R., Aguirre-Zamorano M.A., Escudero-Contreras A., Castro-Villegas M.C., Roldán M.C.F., Ortego N., Raya E., Moleón I.J., de Ramon E., Quintero I.D., Meroni P.L., Gerosa M., Schioppo T., Artusi C., Chizzolini C., Zuber A., Wynar D., Kovács L., Balog A., Deák M., Bocskai M., Dulic S., Kádár G., Hiepe F., Gerl V., Thiel S., Maresca M.R., López-Berrio A., Aguilar-Quesada R., Navarro-Linares H., Hunzelmann N., Moroncini G., de Vries-Bouwstra J.K., Orozco G., Barton A., Herrick A.L., Terao C., Allanore Y., Fonseca C., Alarcón-Riquelme M.E., Radstake T.R.D.J., Beretta L., Denton C.P., Mayes M.D., Martin J.. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine. 2022; 7(1)DOI:10.1038/s41525-022-00327-8. PMID:36198672. IF:5.300(Q1/2D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., García A.S., Cañete J.D., Juanola X., Fiter J., Gratacós J., Rodriguez-Moreno J., Rosa J.N., Martín A.L., García A.B., Segura P.C., Ferrer A.L., Barrio S.P., Plata Izquierdo A.J., Bustabad S., Guimerá Martín-Neda F.J., Capdevilla E.F., Díaz R.R., Cuervo A., Gibert M.A., Larraz P.T., de la Morena Barrio I., Lanza L.P., Sanchís D.B., Mesquida C.M., Murillo C., Moreno Ramos M.J., Beteta M.D., Guillén P.S.-P., Oliveira L.L., Marco T.N., Cebrián L., de la Cueva Dobao P., Steiner M., Muñoz-Fernández S., Garrido R.V., León M., Rubio E., Jiménez A.M., Fernández-Freire L.R., Luezas J.M., Sánchez-González M.D., Muñoz C.S., Senabre J.M., Rosas J.C., Soler G.S., Mataix Díaz F.J., Nieto-González J.C., González C., Ovalles Bonilla J.G., Rodríguez O.B., Medina F.J.N., Luján D., Ruiz Montesino M.D., Carrizosa Esquivel A.M., Fernández-Carballido C., Martínez-Vidal M.P., Fernández L.G., Jovani V., Alameda R.C., Sabater S.G., Romero I.B., Urruticoechea-Arana A., Torres M.S., Almodóvar R., López Estebaranz J.L., López Montilla M.D., García-Nieto A.V.. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. ARTHRITIS RESEARCH & THERAPY. 2022; 24(1)DOI:10.1186/s13075-022-02838-2. PMID:35751091. IF:4.900(Q2/4D).

Kuster S., Jordan S., Elhai M., Held U., Steigmiller K., Bruni C., Cacciapaglia F., Vettori S., Siegert E., Rednic S., Codullo V., Airo P., Braun-Moscovici Y., Hunzelmann N., Joao Salvador M., Riccieri V., Gheorghiu A.-M., Alegre Sancho J.J., Romanowska-Prochnicka K., Castellví I., Kötter I., Truchetet M.-E., López-Longo F.J., Novikov P.I., Giollo A., Shirai Y., Belloli L., Zanatta E., Hachulla E., Smith V., Denton C., Ionescu R.M., Schmeiser T., Distler J.H.W., Gabrielli A., Hoffmann-Vold A.-M., Kuwana M., Allanore Y., Distler O.. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002477. PMID:36328401. IF:6.200(Q1/2D).

Balsa A., González-Álvaro I., Sanmartí R., Corominas H.. How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2021.08.002. PMID:34489191. IF:(Q/D).

Narváez J., Díaz del Campo Fontecha P., Brito García N., Bonilla G., Aburto M., Castellví I., Cano-Jiménez E., Mena-Vázquez N., Nieto M.A., Ortiz A.M., Valenzuela C., Abad Hernández M.Á., Castrejón I., Correyero Plaza M., Francisco Hernández F.M., Hernández Hernández M.V., Rodríquez Portal J.A.. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. IF:(Q/D).

Rodríguez Portal J.A., Brito García N., Díaz del Campo Fontecha P., Valenzuela C., Ortiz A.M., Nieto M.A., Mena-Vázquez N., Cano-Jiménez E., Castellví I., Aburto M., Bonilla G., Hernández Hernández M.V., Hernández F.M.F., Correyero Plaza M., Castrejón I., Abad Hernández M.Á., Narváez J.. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8)DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. IF:(Q/D).

Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8). Rheumatology and Therapy. 2022; 9(4)DOI:10.1007/s40744-022-00463-8. PMID:35653064. IF:3.800(Q3/6D).

Cobo-Ibáñez T., Sánchez-Piedra C., Nuño-Nuño L., Castellví I., Carrión-Barberà I., Romero-Bueno F., Narváez J., Trallero-Araguás E., Tomero E., Ruiz-Lucea M.E., Larena C., Carrasco Cubero C., Jovaní V., Barbadillo C., Sivera F., Belzunegui J., Pérez Gómez A., Gómez Gómez A., Delgado-Frías E., Pego-Reigosa J.M., Joven B., Ibáñez M., Martínez-González O., Ruiz-Román A., Camins J., Ortega-Castro R., Trenor Larra P., Rodríguez López M., Freire M., Alcocer P., Holgado S., Rúa-Figueroa I., Lozano N., Martínez-Barrio J.. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5)DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. IF:(Q/D).

Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Pinto Tasende J.A., Bethencourt Baute J.J., Joven Ibáñez B., Toniolo E., Ramírez J., Pruenza García-Hinojosa C.. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3.900(Q2/4D).

Mir-Perelló C., López B.M., Pérez B.S., Torrent R.B., Fernández M.I.G., Corbeto M.L., Gil J.G., Zavala R.G.. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94)DOI:. PMID:. IF:(Q/D).

Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study). Rheumatology and Therapy. 2022; 9(2)DOI:10.1007/s40744-021-00423-8. PMID:35041155. IF:3.800(Q3/6D).

Company-Se, G, Nescolarde, L, Pajares, V, Torrego, A, Riu, PJ, Rosell, J, Bragos, R. Minimally Invasive Lung Tissue Differentiation Using Electrical Impedance Spectroscopy: A Comparison of the 3-and 4-Electrode Methods. IEEE Access. 2022; 10DOI:10.1109/ACCESS.2021.3139223. PMID:. IF:3.900(Q2/4D).

Carrillo, DD, Martinez-Garcia, MA, Barreiro, E, Huguet, ET, Sola, RC, Garcia-Clemente, MM, Jimenez, NC, Pons, LR, Acuna, CC, Hermosa, JLR, Golpe, R, Quintas, RD, Sanchez-Cuellar, S, Arroyo, IT, Aparicio, MB, Pacheco, VA, Miravitlles, M. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(1)DOI:10.1016/j.arbres.2021.03.009. PMID:33849721. IF:8.000(Q1/2D).

Villegas, DC, Barril, S, Giner, J, Millan-Billi, P, Rodrigo-Troyano, A, Merino, JL, Sibila, O. Study of Diffuse Interstitial Lung Disease With the Analysis of Volatile Particles in Exhaled Air. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(1)DOI:10.1016/j.arbres.2021.03.014. PMID:33867204. IF:8.000(Q1/2D).

Wang X., Villa C., Dobarganes Y., Olveira C., Girón R., García-Clemente M., Máiz L., Sibila O., Golpe R., Menndez R., Rodríguez-López J., Prados C., Martinez-García M.A., Rodriguez J.L., De La Rosa D., Duran X., Garcia-Ojalvo J., Barreiro E.. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020225. PMID:35203435. IF:4.700(Q1/3D).

Conticini, E, d'Alessandro, M, Bergantini, L, Castillo, D, Cameli, P, Frediani, B, Cantarini, L, Bargagli, E. KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach. Biology-Basel. 2022; 11(1)DOI:10.3390/biology11010094. PMID:35053092. IF:4.200(Q2/3D).

De Llano, LP, Rivas, DD, Malanda, NM, Moral, VP, Blanco, JAG, Munoz-Esquerre, M, Garcia-Moguel, I, Campos, RMD, Martinez-Moragon, E, Mena, AH, Cosio, BG, Galo, AP, Serrano, CC. The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome. Journal of Asthma and Allergy. 2022; 15DOI:10.2147/JAA.S338467. PMID:35330786. IF:3.200(Q3/6D).

Company-Se, G, Nescolarde, L, Pajares, V, Torrego, A, Riu, PJ, Rosell, J, Bragos, R. Effect of Calibration for Tissue Differentiation Between Healthy and Neoplasm Lung Using Minimally Invasive Electrical Impedance Spectroscopy. IEEE Access. 2022; 10DOI:10.1109/ACCESS.2022.3209809. PMID:. IF:3.900(Q2/4D).

Romero, JD, Blanco-Aparicio, M, Serrano, CC, Diaz-Perez, D, Piqueres, RF, Lopez-Carrasco, V, Merino-Bohorquez, V, Soto-Retes, L, Dominguez-Ortega, J. Support for Home Administration of Biological Therapy in Patients With Severe Asthma: BioCart (c). JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2022; 32(6)DOI:10.18176/jiaci.0786. PMID:35088761. IF:7.200(Q1/2D).

Cendon L., Rafecas Codern A., De La Rosa D., Castellví I., Spagnolo P., Castillo D.. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia. Open Respiratory Archives. 2022; 4(4)DOI:10.1016/j.opresp.2022.100211. PMID:. IF:(Q/D).

Quint J.K., Arnetorp S., Kocks J.W.H., Kupczyk M., Nuevo J., Plaza V., Cabrera C., Raherison-Semjen C., Walker B., Penz E., Gilbert I., Lugogo N.L., van der Valk R.J.P., Fong A., Qian C., Fabry-Vendrand C., Touboul C., Brzostek D., Maslova E., Surmont F., Goike H., Gandhi H., Korevaar J.C., Tkacz J., Johnston K., Peres da Costa K., van Dijk L., Vervloet M., Pollack M., Hernandez P., Boarino S., Noorduyn S.G., Beekman-Hendricks W., Weesie Y.M.. Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America. Journal of Allergy and Clinical Immunology-In Practice. 2022; 10(9)DOI:10.1016/j.jaip.2022.02.047. PMID:35364341. IF:9.400(Q1/2D).

Alvarez-Gutiérrez F.J., Blanco-Aparicio M., Casas-Maldonado F., Plaza V., González-Barcala F.J., Carretero-García J.Á., Castilla-Martínez M., Cisneros C., Diaz-Pérez D., Domingo-Ribas C., Martínez-Moragon E., Muñoz X., Padilla-Galo A., Perpiñá-Tordera M., Soto-Campos G.. Consensus document for severe asthma in adults. 2022 update. Open Respiratory Archives. 2022; 4(3)DOI:10.1016/j.opresp.2022.100192. PMID:. IF:(Q/D).

Villar-Álvarez F., de la Rosa-Carrillo D., Fariñas-Guerrero F., Jiménez-Ruiz C.A.. Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory Patient. Open Respiratory Archives. 2022; 4(3)DOI:10.1016/j.opresp.2022.100181. PMID:. IF:(Q/D).

Zapater A., Solelhac G., Sánchez-de-la-Torre A., Gracia-Lavedan E., Benitez I.D., Torres G., De Batlle J., Haba-Rubio J., Berger M., Abad J., Duran-Cantolla J., Urrutia A., Mediano O., Masdeu M.J., Ordax-Carbajo E., Masa J.F., De la Peña M., Mayos M., Coloma R., Montserrat J.M., Chiner E., Mínguez O., Pascual L., Cortijo A., Martínez D., Dalmases M., Lee C.-H., McEvoy R.D., Barbé F., Heinzer R., Sánchez-de-la-Torre M.. Respiratory Polygraphy Patterns and Risk of Recurrent Cardiovascular Events in Patients With Acute Coronary Syndrome. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.870906. PMID:35833104. IF:3.900(Q2/4D).

Oliveira L.F.D., Mallafré-Muro C., Giner J., Perea L., Sibila O., Pardo A., Marco S.. Breath analysis using electronic nose and gas chromatography-mass spectrometry: A pilot study on bronchial infections in bronchiectasis. CLINICA CHIMICA ACTA. 2022; 526DOI:10.1016/j.cca.2021.12.019. PMID:34953821. IF:5.000(Q1/2D).

de la Rosa-Carrillo D., Suárez-Cuartín G., Golpe R., Martinez-Garcia M.A., Carro L.M.. Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence. Infection and Drug Resistance. 2022; 15DOI:10.2147/IDR.S318173. PMID:36540105. IF:3.900(Q2/4D).

Peñacoba Toribio P., Fortuna Gutiérrez A.M., Mayos Pérez M.. Management of obstructive sleep apnea in primary care in relation to the new international consensus document. Open Respiratory Archives. 2022; 4(1)DOI:10.1016/j.opresp.2021.100150. PMID:. IF:(Q/D).